In this study, bile duct ligation was conducted to induce an animal model of extrahepatic cholestasis, targeting the PI3K/AKT/GSK-3β signaling pathway and intestinal flora, to investigate the therapeutic effect of SAL on obstructive cholestatic liver fibrosis and its mechanism. This evidence concerns the gene AKT1 and extrahepatic cholestasis.